Denatured collagen type IV

Denatured collagen type IV is a modified form of the primary structural protein of the basement membrane, produced when the native triple-helical structure is disrupted by heat or proteolytic enzymes like matrix metalloproteinases (MMPs) (Xu et al., 2001). This denaturation process exposes cryptic epitopes, such as HUIV26 and HUI77, which are hidden in the intact molecule and serve as specific binding sites for integrins like alpha-v-beta-3 on the surface of migrating endothelial and tumor cells (Hangai et al., 2002). These interactions are critical for pathological processes, including angiogenesis, tumor invasion, and metastasis, making denatured collagen IV a distinct marker of tissue remodeling (Brooks et al., 1998). Unlike native collagen IV, which provides structural stability, the denatured form actively promotes the growth of new blood vessels and the spread of cancer cells (Petitclerc et al., 2000). Therapeutic targeting of these cryptic sites using monoclonal antibodies or utilizing endogenous collagen IV fragments like Tumstatin and Canstatin offers a strategy to selectively inhibit disease-associated angiogenesis while minimizing effects on healthy, stable vasculature (Colorado et al., 2000). This specificity makes denatured collagen IV a promising target for treating various cancers and neovascular ocular diseases such as diabetic retinopathy (Hamano et al., 2003).

Other names

Cryptic collagen IV epitopesProteolyzed collagen IVUnfolded collagen IVMMP-cleaved collagen IVHUIV26 epitopeHUI77 epitope

Selective inhibition of integrin binding to cryptic epitopes exposed during collagen IV denaturation to suppress angiogenesis and tumor progression.